Eripheson Tablet 50 mg (Eperisone Hydrochloride)

Adult dose

As Eperisone Hydrochloride, 50 mg is administered orally three times a day after meals. The dose may be adjusted appropriately according to age and symptoms.

This medication should not be used in certain patients. First, patients with known allergic reactions to this medication or those with myasthenia gravis should not take it. Additionally, this medication contains lactose, so patients with lactose intolerance or certain genetic metabolic disorders should avoid it. Some patients require caution when using this medication. Patients with a history of hypersensitivity to drugs or those with impaired liver function should be carefully reviewed before taking it. Special attention is needed as liver function may deteriorate. During the use of this medication, various side effects may occur; symptoms should be closely monitored. Rarely, shock may occur, and if symptoms appear, administration should be stopped immediately and appropriate treatment sought. Liver function test values may rise, and if abnormal signs are detected, administration should be halted. It may also affect kidney function, so if proteinuria or abnormal blood test results are found, caution is required. Allergic reactions such as anemia, skin rash, and itching may occur. Central nervous system symptoms, including insomnia, drowsiness, headaches, and limb paralysis, have been reported. Gastrointestinal symptoms such as nausea, vomiting, loss of appetite, and abdominal pain may also occur, so care is needed. Urinary symptoms may include urinary retention or incontinence. Systemically, fatigue, dizziness, and reduced muscle tone may occur, thus careful observation is needed. Rarely, facial flushing, sweating, and swelling may also occur. Additionally, serious allergic reactions or serious skin adverse reactions like Stevens-Johnson syndrome may appear, and if symptoms like fever, erythema, blistering, itching, conjunctival injection, or stomatitis arise, administration should be stopped immediately. Generally, while taking this medication, weakness, staggering, or drowsiness may occur; if such symptoms are present, it is advisable to reduce or stop the dosage. Since drowsiness or concentration impairment may occur, driving or operating hazardous machinery should be avoided. When taking this medication with similar drugs, interactions such as visual disturbances have been reported, so caution is necessary. During pregnancy, the safety of this medication is not assured, so women who are pregnant or may become pregnant should only use it when the therapeutic benefits outweigh the risks. For breastfeeding mothers, it is preferable to avoid taking it, and if it must be taken, breastfeeding should be discontinued. The safety in children has not been sufficiently established, so it should be used with caution. In elderly patients, body function may be impaired, so special care in adjusting the dosage is required.

Serious side effects

Shock (severe allergic reaction), anaphylaxis (severe allergic reaction), angioedema (severe swelling), toxic epidermal necrolysis and mucosal-cutaneous-ocular syndrome (Stevens-Johnson syndrome) (severe skin adverse reactions), liver dysfunction indicated by elevated ALT, AST, ALP (liver dysfunction), proteinuria, elevated BUN (kidney dysfunction), anemia, and edema (severe swelling).

Mild side effects

• Occasionally rash
• itching
• insomnia
• drowsiness
• headache
• muscle stiffness
• limb tremors
• nausea
• vomiting
• loss of appetite

This medication should be stored in a tightly sealed container to prevent air from entering, and it is best stored at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication and prevent deterioration.

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle